The authors present planning, process, compliance, and copyright considerations for both author- and sponsor-led publication enhancers.
It’s time to move omnichannel from discussion to reality using the steps: Observe, Plan, Engage and Nurture.
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics.
In the KOL Omnichannel Engagement ecosystem, MSLs must be empowered as the center of cross-functional omnichannel engagement. This is particularly important in the Pipeline Education, Pre-Launch, and Newly Launched scenarios, where MSLs play a crucial role in delivering the latest scientific information to KOLs. To ensure that MSLs are set up for success in their expanded role, there must be an aligned view of their scientific leadership value within the cross-functional organization. Then, it is critical to enable and design relevant people, process, and technology practices to support. To optimize KOL Omnichannel Engagement, the life science industry must recognize the importance of the multifaceted MSL role.
The Objectives of this webinar are:
In this podcast, experts from the “Optimize your Field Medical Team for the Omnichannel World” workshop at the MAPS 2023 America’s Conference discuss the outcomes & insights of that workshop & how Field Medical can build skills & garner support to effectively implement omnichannel strategies.
This white paper by the MAPS Field Medical FAWG details strategies for optimizing your Field Medical team for the OmniChannel World
In the second podcast of this two-part series, we will discuss communicating the value of Field Medical to external stakeholders.
In this first podcast, the first of a two-part series, we will discuss communicating the value of Field Medical to internal stakeholders.
Customer engagements for Medical Affairs has evolved rapidly post COVID-19. Hybrid is the future and that brings with it new challenges, most notably in sustaining engagements with the KOLs to become unbiased scientific partners of choice. As a result, there have been shifts in strategies: newer roles, newer stakeholders to be engaged, and more data and information collected.
There is no one-size-fits-all approach. The intent of this webinar will be to have a discussion on which strategies are working, and how leading companies are defining success for field medical teams in hybrid engagements.
Based on discussions between 80 cross-industry Field Medical colleagues from small to large biopharmaceutical and medtech companies, this article highlights key actions for Medical Affairs teams to consider for implementation in their own organizations.